期刊
MOVEMENT DISORDERS
卷 27, 期 2, 页码 312-315出版社
WILEY-BLACKWELL
DOI: 10.1002/mds.24029
关键词
Parkinson's disease; alpha-synuclein; Sanfilippo syndrome; lysosomal disorders; genetics
资金
- NIHR Biomedical Research Centre
- University of Cambridge and Parkinson's UK
- Medical Research Council [G0000934]
- Wellcome Trust [068545/Z/02]
- Merck
- Sharp
- Dohme
- University of Cambridge
- UK NIHR
- PPP Healthcare Foundation
- Medical Research Council [G0800784, G0000934, G0800784B] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish
- Parkinson's UK [G-1102, J-0804] Funding Source: researchfish
- MRC [G0000934, G0800784] Funding Source: UKRI
Background: Parkinson's disease (PD) is a common neurodegenerative disorder of unknown etiology. The characteristic a-synuclein aggregation of PD is also a feature of Sanfilippo syndrome, a storage disorder caused by a-N-acetylglucosaminidase (NAGLU) gene mutations. We explored genetic links between these disorders and studied the pathology of Sanfilippo syndrome to investigate a common pathway toward a-synuclein aggregation. Methods: We typed the 2 single-nucleotide polymorphisms that tag the common haplotypes of NAGLU in 926 PD patients and 2308 controls and also stained cortical tissue from 2 cases of Sanfilippo A syndrome using the anti-a-synuclein antibody, Per7. Results: Allelic analysis showed an association between rs2071046 and risk for PD (P 1.3 x 10(-3)). Intracellular alpha-synuclein accumulation was observed in the cortical tissue of both Sanfilippo A syndrome cases. Conclusions: This study suggests a possible role of NAGLU in susceptibility to PD while extending evidence for a-synuclein aggregation in the brain in lysosomal storage disorders. Our findings support a mechanism involving lysosomal dysfunction more generally in the pathogenesis of PD. (C) 2011 Movement Disorder Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据